Quick summary: Semaglutide is an FDA-approved GLP-1 receptor agonist that reduces appetite and supports sustained weight loss when combined with lifestyle changes. At OC Weight Loss & Med Spa in Mission Viejo, CA, treatment is supervised by physician Dr. Nezar Dahdal, MD and administered under the care of Lindsay Short, NP. Individual results vary, and candidacy is determined at a medical consultation. This article explains how semaglutide works, what the clinical evidence shows, and who should not use it.
Medically reviewed by the clinical team at OC Weight Loss & Med Spa. Last updated: June 12, 2026.
What Is Semaglutide?
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist — a class of medication originally developed to treat type 2 diabetes. The FDA has approved higher-dose semaglutide formulations specifically for chronic weight management in adults who meet clinical criteria.
GLP-1 is a hormone your gut releases after eating. It signals the pancreas to produce insulin, slows gastric emptying, and communicates with the brain’s appetite-regulating centers to reduce hunger. Semaglutide mimics these effects at a sustained level, producing a consistent reduction in appetite and caloric intake over time.
How Semaglutide Supports Weight Loss
The medication works through several complementary mechanisms:
- Appetite reduction: GLP-1 receptors in the hypothalamus receive stronger satiety signals, so you feel full with less food.
- Slower gastric emptying: Food moves more gradually through the stomach, extending the feeling of fullness after meals.
- Improved blood sugar regulation: By stimulating insulin release in response to meals and suppressing glucagon, semaglutide helps stabilize post-meal glucose — relevant for patients with insulin resistance.
In clinical trials, patients on higher-dose semaglutide combined with lifestyle intervention lost, on average, a meaningful percentage of body weight over 68 weeks compared with placebo. Individual results vary based on adherence, diet, activity level, and metabolic factors.
What to Expect During Treatment
Semaglutide for weight management is administered as a once-weekly subcutaneous injection — typically in the abdomen, thigh, or upper arm. Treatment at OC Weight Loss & Med Spa follows a structured protocol:
- Initial consultation: Lindsay Short, NP reviews your medical history, current medications, lab work, and weight-loss goals to determine whether semaglutide is appropriate and what starting dose is safe.
- Dose escalation: Treatment typically starts at a low dose, increasing gradually over several weeks to minimize GI side effects and allow your body to adjust.
- Ongoing monitoring: Follow-up appointments track progress, assess tolerability, and adjust the plan as needed. Semaglutide is most effective alongside a calorie-conscious diet and regular physical activity — not as a standalone solution.
Most patients begin noticing reduced appetite within the first few weeks. Meaningful changes in body weight typically become apparent over the first two to three months of consistent use.
Safety, Side Effects, and Who Should Not Use Semaglutide
Semaglutide has a well-studied safety profile, but it is a prescription medication with real risks that every patient should understand before starting.
Common side effects include nausea, vomiting, diarrhea, constipation, and abdominal discomfort. These are most frequent during the dose-escalation phase and typically diminish as the body adapts. Eating smaller meals and staying well-hydrated often helps.
Serious risks to discuss with your provider:
- Thyroid C-cell tumors (boxed warning): In rodent studies, semaglutide caused thyroid C-cell tumors at clinically relevant exposures. Whether this translates to humans is not established, but the drug carries an FDA boxed warning. Patients with a personal or family history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2) should not use semaglutide.
- Pancreatitis: Acute pancreatitis has been reported. Discontinue use and seek medical care if you experience severe, persistent abdominal pain.
- Gallbladder disease: GLP-1 agonists have been associated with an increased risk of cholelithiasis (gallstones) and cholecystitis.
- Hypoglycemia: When semaglutide is combined with insulin or sulfonylureas, low blood sugar risk increases. Your provider will review your full medication list.
- Pregnancy and nursing: Semaglutide is not recommended during pregnancy or breastfeeding. Adequate contraception is advised for women of childbearing potential.
Who should not use semaglutide: Patients with a personal or family history of MTC or MEN 2, known hypersensitivity to semaglutide or its excipients, or who are pregnant. Candidacy for treatment is always determined at a medical consultation with a qualified provider.
Frequently Asked Questions
How long does it take to see results with semaglutide?
Most patients notice a reduction in appetite within the first one to two weeks. Visible changes in body weight generally accumulate over the first two to three months of consistent treatment. Results depend on adherence to the medication schedule, dietary habits, and physical activity. Individual results vary.
Is semaglutide the same as Ozempic or Wegovy?
Ozempic and Wegovy both contain semaglutide, but they are FDA-approved for different indications and use different dosing protocols. Ozempic is approved for type 2 diabetes management; Wegovy is approved specifically for chronic weight management at a higher maintenance dose. Your provider will explain which formulation or protocol is appropriate for your situation.
Do I have to stay on semaglutide indefinitely?
Research indicates that patients who discontinue semaglutide without maintaining lifestyle changes tend to regain a significant portion of lost weight. Your provider will discuss what a responsible exit strategy or maintenance plan looks like based on your progress and goals.
Can I use semaglutide if I have type 2 diabetes?
GLP-1 agonists were originally developed for type 2 diabetes and have a strong evidence base in that population. If you have diabetes and are also seeking weight management support, your provider will coordinate with your endocrinologist or primary care physician to avoid medication conflicts and ensure safe dosing.
What does the semaglutide program at OC Weight Loss & Med Spa include?
The program begins with a medical consultation to assess your eligibility. If appropriate, a personalized protocol is developed that includes dose escalation, nutritional guidance, follow-up monitoring, and ongoing support from Lindsay Short, NP under the supervision of Dr. Nezar Dahdal, MD. Financing options including Cherry, CareCredit, and Alle are available.
Ready to Learn Whether Semaglutide Is Right for You?
Semaglutide is a clinically studied tool, not a shortcut. When prescribed appropriately and monitored by a qualified provider, it can meaningfully support weight loss for patients who have not achieved their goals through diet and exercise alone. The team at OC Weight Loss & Med Spa in Mission Viejo, CA offers a free initial consultation to determine whether this or another medically supervised approach fits your health profile. Call (949) 416-0950 or book online.
Book a free consultation
Book a Free Consultation